Last updated on April 2018

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Brief description of study

The primary objective of this study is to determine whether the use of PDE5 inhibitors (vardenafil, sildenafil, or tadalafil) increases the risk for the development of NAION.

Detailed Study Description

Collected data will be compared to historic data of the same participant in case-crossover design.

Clinical Study Identifier: NCT00867815

Contact Investigators or Research Sites near you

Start Over

Vision Eye Institute

Chatswood, Australia

Save Sight Institute

Sydney, Australia

Annandale Eye Care

Annandale, Australia

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.